Company:  SYNTA PHARMACEUTICALS COR ... (SNTA)
Form Type:  10-Q
Filing Date:  8/2/2012 
CIK:  0001157601 
Address:  45 HARTWELL AVE 
City, State, Zip:  LEXINGTON, Massachusetts 02421 
Telephone:  781-274-8200 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.97  
Change: 
-0.07 (-1.73%)  
Trade Time: 
Apr 17  
Market Cap: 
$363.78M
Description of Business
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      Item 1. Financial Statements.
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        Notes to Condensed Consolidated Financial Statements
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        INCOME STATEMENT
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures.
    PART II - OTHER INFORMATION
      Item 1. Legal Proceedings.
      Item 1A. Risk Factors.
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 3. Defaults Upon Senior Securities.
      Item 4. Mine Safety Disclosures.
      Item 5. Other Information.
      Item 6. Exhibits.
    SIGNATURES
  EXHIBIT 10.2
  EXHIBIT 31.1
    CERTIFICATIONS UNDER SECTION 302
  EXHIBIT 31.2
    CERTIFICATIONS UNDER SECTION 302
  EXHIBIT 32.1
    CERTIFICATIONS UNDER SECTION 906
BROKERAGE PARTNERS